Neuronetics Inc STIM

US Health Care

$1.98 ▲ +0.51% (+$0.01)

🔥 High Short Interest 📅 Earnings This Week

Open $1.98

Prev Close $1.97

Day Range $1.91 – $2.10

52W Range $0.80 – $4.85

Market Cap $137.78M

Beta 1.12

EPS (TTM) $-0.55

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2018-06-28
Shares Out.	69,590,000
Website	neurostar.com/neuronetics/ ↗
Phone	13026587581
Employees	658
Revenue	$34.5M
Gross Profit	$16.2M
Net Income	-$10.8M
Free Cash Flow	-$13.6M
Total Assets	$125.4M
Total Liabilities	$108.4M
Equity	$17.1M

About Neuronetics Inc

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Neuronetics Inc is a publicly traded company under the ticker symbol STIM on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.